136 related articles for article (PubMed ID: 15514195)
1. Elastin and calcium rather than collagen or lipid content are associated with echogenicity of human carotid plaques.
Gonçalves I; Lindholm MW; Pedro LM; Dias N; Fernandes e Fernandes J; Fredrikson GN; Nilsson J; Moses J; Ares MP
Stroke; 2004 Dec; 35(12):2795-800. PubMed ID: 15514195
[TBL] [Abstract][Full Text] [Related]
2. Semiautomated Magnetic Resonance Imaging Assessment of Carotid Plaque Lipid Content.
Skagen K; Evensen K; Scott H; Krohg-Sørensen K; Vatnehol SA; Hol PK; Skjelland M; Russell D
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2004-10. PubMed ID: 27234919
[TBL] [Abstract][Full Text] [Related]
3. Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans.
Vik A; Mathiesen EB; Notø AT; Sveinbjørnsson B; Brox J; Hansen JB
Atherosclerosis; 2007 Mar; 191(1):128-34. PubMed ID: 16620835
[TBL] [Abstract][Full Text] [Related]
4. Cerebral embolism during carotid artery stenting: role of carotid plaque echolucency.
Rosenkranz M; Wittkugel O; Waiblinger C; Thomalla G; Krutzelmann A; Havemeister S; Zeumer H; Gerloff C; Fiehler J
Cerebrovasc Dis; 2009; 27(5):443-9. PubMed ID: 19295207
[TBL] [Abstract][Full Text] [Related]
5. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromsø study.
Mathiesen EB; Bønaa KH; Joakimsen O
Circulation; 2001 May; 103(17):2171-5. PubMed ID: 11331258
[TBL] [Abstract][Full Text] [Related]
6. Increase in echogenicity of echolucent carotid plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled, randomized trial.
Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Bucci M; Dugall M; De Sanctis MT; Incandela L; Griffin M; Sabetai M
Angiology; 2001 Oct; 52 Suppl 2():S19-25. PubMed ID: 11666118
[TBL] [Abstract][Full Text] [Related]
7. Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques.
Notø AT; Mathiesen EB; Brox J; Björkegren J; Hansen JB
Lipids; 2008 Apr; 43(4):353-60. PubMed ID: 18320250
[TBL] [Abstract][Full Text] [Related]
8. Echogenicity of medium-to-large carotid plaques predicts future vascular events.
Tadokoro Y; Sakaguchi M; Yamagami H; Okazaki S; Furukado S; Matsumoto M; Miwa K; Yagita Y; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2014; 38(5):354-61. PubMed ID: 25427642
[TBL] [Abstract][Full Text] [Related]
9. 18FDG PET and ultrasound echolucency in carotid artery plaques.
Graebe M; Pedersen SF; Højgaard L; Kjaer A; Sillesen H
JACC Cardiovasc Imaging; 2010 Mar; 3(3):289-95. PubMed ID: 20223427
[TBL] [Abstract][Full Text] [Related]
10. Increased thrombin generation in persons with echogenic carotid plaques.
With Notø AT; Mathiesen EB; Østerud B; Amiral J; Vissac AM; Hansen JB
Thromb Haemost; 2008 Mar; 99(3):602-8. PubMed ID: 18327410
[TBL] [Abstract][Full Text] [Related]
11. Increased echolucency of carotid plaques in patients with type 2 diabetes.
Ostling G; Hedblad B; Berglund G; Gonçalves I
Stroke; 2007 Jul; 38(7):2074-8. PubMed ID: 17525393
[TBL] [Abstract][Full Text] [Related]
12. Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques.
Gonçalves I; Moses J; Dias N; Pedro LM; Fernandes e Fernandes J; Nilsson J; Ares MP
Stroke; 2003 Mar; 34(3):616-22. PubMed ID: 12624281
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity.
Skjelland M; Michelsen AE; Krohg-Sørensen K; Tennøe B; Dahl A; Bakke S; Brosstad F; Damås JK; Russell D; Halvorsen B; Aukrust P
Atherosclerosis; 2007 Dec; 195(2):e142-6. PubMed ID: 17568588
[TBL] [Abstract][Full Text] [Related]
14. Modification of the echogenicity of femoral plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, randomized, placebo-controlled trial.
Incandela L; Belcaro G; Nicolaides AN; Cesarone MR; De Sanctis MT; Corsi M; Bavera P; Ippolito E; Griffin M; Geroulakos G; Sabetai M; Ramaswami G; Veller M
Angiology; 2001 Oct; 52 Suppl 2():S69-73. PubMed ID: 11666127
[TBL] [Abstract][Full Text] [Related]
15. Utility of the assessment of echogenicity in the identification of symptomatic carotid artery atheroma plaques in ischemic stroke patients.
Ruiz-Ares G; Fuentes B; Martínez-Sánchez P; Martínez-Martínez M; Díez-Tejedor E
Cerebrovasc Dis; 2011; 32(6):535-41. PubMed ID: 22104509
[TBL] [Abstract][Full Text] [Related]
16. Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels.
Grønholdt ML; Nordestgaard BG; Bentzon J; Wiebe BM; Zhou J; Falk E; Sillesen H
J Vasc Surg; 2002 Jan; 35(1):137-45. PubMed ID: 11802145
[TBL] [Abstract][Full Text] [Related]
17. Echolucency of carotid plaques and cerebrovascular events.
Aldemir E; Apaydin M; Varer M; Uluc E
J Clin Ultrasound; 2012 Sep; 40(7):399-404. PubMed ID: 22678951
[TBL] [Abstract][Full Text] [Related]
18. The role of carotid plaque echogenicity in baroreflex sensitivity.
Tsekouras NS; Katsargyris A; Skrapari I; Bastounis EE; Georgopoulos S; Klonaris C; Bakoyiannis C; Bastounis EA
J Vasc Surg; 2011 Jul; 54(1):93-9. PubMed ID: 21458208
[TBL] [Abstract][Full Text] [Related]
19. Echolucency of carotid plaques correlates with plaque cellularity.
Gonçalves I; Moses J; Pedro LM; Dias N; Fernandes e Fernandes J; Nilsson J; Ares MP
Eur J Vasc Endovasc Surg; 2003 Jul; 26(1):32-8. PubMed ID: 12819645
[TBL] [Abstract][Full Text] [Related]
20. Echolucent rupture-prone plaques.
Nordestgaard BG; Grønholdt ML; Sillesen H
Curr Opin Lipidol; 2003 Oct; 14(5):505-12. PubMed ID: 14501590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
